Lactoferrin and Its Peptides: A Natural Weapon Against Drug-Resistant Pathogens
Lactoferrin and lactoferricin peptides combat pathogens through multiple mechanisms — from iron sequestration to membrane disruption — with no known pathogen resistance and synergy with existing drugs.
Quick Facts
What This Study Found
Lactoferrin and lactoferricins combat pathogens through iron sequestration, membrane disruption, biofilm inhibition, toxin neutralization, and virulence factor inhibition, with no reported pathogen resistance and demonstrated synergy with antimicrobial drugs.
Key Numbers
Multiple antimicrobial mechanisms documented: bacteriostatic, bactericidal, anti-biofilm, anti-virulence, immune-stimulating.
How They Did This
Comprehensive review of published literature on lactoferrin and lactoferricin antimicrobial mechanisms against bacteria, protozoa, fungi, and viruses.
Why This Research Matters
With antibiotic resistance threatening modern medicine, lactoferrin represents a multi-mechanism natural antimicrobial that pathogens haven't been able to evolve resistance against — a rare and valuable property.
The Bigger Picture
The antimicrobial resistance crisis demands new approaches. Lactoferrin's multiple mechanisms of action, lack of resistance development, and synergy with existing drugs position it as both a standalone alternative and a combination therapy enhancer for drug-resistant infections.
What This Study Doesn't Tell Us
Review focuses on in vitro and preclinical evidence — clinical trial data for lactoferrin as an antimicrobial therapy is limited. Optimal dosing, delivery methods, and clinical indications need further investigation.
Questions This Raises
- ?Can lactoferrin-based therapies be developed for clinical use against drug-resistant infections?
- ?What is the optimal combination of lactoferrin with existing antibiotics for different pathogen types?
- ?Could oral or topical lactoferrin formulations provide effective antimicrobial protection?
Trust & Context
- Key Stat:
- Zero resistance no pathogen has developed resistance to lactoferrin or lactoferricins
- Evidence Grade:
- Comprehensive review with extensive preclinical evidence. Clinical trial data is limited but the breadth of antimicrobial mechanisms is well-documented.
- Study Age:
- Published in 2020. Lactoferrin research has accelerated, particularly during and after the COVID-19 pandemic.
- Original Title:
- Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.
- Published In:
- Molecules (Basel, Switzerland), 25(24) (2020)
- Authors:
- Zarzosa-Moreno, Daniela, Avalos-Gómez, Christian, Ramírez-Texcalco, Luisa Sofía, Torres-López, Erick, Ramírez-Mondragón, Ricardo, Hernández-Ramírez, Juan Omar, Serrano-Luna, Jesús, de la Garza, Mireya
- Database ID:
- RPEP-05229
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Where does lactoferrin come from?
Lactoferrin is a natural protein found in high concentrations in breast milk and colostrum, and is also produced by white blood cells. It's commercially available from bovine milk.
Why haven't pathogens developed resistance to lactoferrin?
Lactoferrin attacks pathogens through multiple mechanisms simultaneously — starving them of iron, damaging their membranes, blocking their attachment, and neutralizing their toxins. It's very difficult for pathogens to develop resistance to so many different attacks at once.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05229APA
Zarzosa-Moreno, Daniela; Avalos-Gómez, Christian; Ramírez-Texcalco, Luisa Sofía; Torres-López, Erick; Ramírez-Mondragón, Ricardo; Hernández-Ramírez, Juan Omar; Serrano-Luna, Jesús; de la Garza, Mireya. (2020). Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.. Molecules (Basel, Switzerland), 25(24). https://doi.org/10.3390/molecules25245763
MLA
Zarzosa-Moreno, Daniela, et al. "Lactoferrin and Its Derived Peptides: An Alternative for Combating Virulence Mechanisms Developed by Pathogens.." Molecules (Basel, 2020. https://doi.org/10.3390/molecules25245763
RethinkPeptides
RethinkPeptides Research Database. "Lactoferrin and Its Derived Peptides: An Alternative for Com..." RPEP-05229. Retrieved from https://rethinkpeptides.com/research/zarzosa-moreno-2020-lactoferrin-and-its-derived
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.